Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.410
-0.080 (-3.21%)
At close: Nov 20, 2024, 4:00 PM
2.580
+0.170 (7.05%)
Pre-market: Nov 21, 2024, 7:33 AM EST
Lipella Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 1.35 | 3.29 | 5.12 | 1.41 | 0.61 | 0.03 |
Short-Term Investments | - | - | - | 0.3 | - | - |
Cash & Short-Term Investments | 1.35 | 3.29 | 5.12 | 1.71 | 0.61 | 0.03 |
Cash Growth | -43.82% | -35.69% | 198.75% | 182.56% | 2233.15% | - |
Other Receivables | 0.03 | 0.03 | 0.11 | - | 0.07 | 0.08 |
Receivables | 0.03 | 0.03 | 0.11 | - | 0.07 | 0.08 |
Prepaid Expenses | 0.7 | 0.1 | 0.56 | 0.09 | 0.02 | 0.01 |
Total Current Assets | 2.08 | 3.43 | 5.8 | 1.81 | 0.7 | 0.12 |
Property, Plant & Equipment | 0.08 | 0.15 | 0.15 | 0.2 | 0.26 | - |
Accounts Payable | 0.46 | 0.14 | 0.38 | 0.05 | 0.02 | 0.05 |
Accrued Expenses | 0.17 | 0.16 | 0.46 | 0.23 | 0.11 | 0.07 |
Short-Term Debt | - | - | 0.28 | 0.03 | 0.03 | 0.05 |
Current Portion of Leases | 0.07 | 0.09 | 0.06 | 0.04 | 0.05 | - |
Other Current Liabilities | - | - | - | - | 0 | - |
Total Current Liabilities | 0.7 | 0.39 | 1.18 | 0.34 | 0.21 | 0.17 |
Long-Term Debt | - | - | - | 0.05 | 0.05 | 0.05 |
Long-Term Leases | - | 0.05 | 0.1 | 0.17 | 0.21 | - |
Other Long-Term Liabilities | 0 | - | - | 0.03 | 0.03 | 0.02 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 15.36 | 13.47 | 10.38 | 4.53 | 1.7 | 1.06 |
Retained Earnings | -13.9 | -10.32 | -5.7 | -3.11 | -1.24 | -1.18 |
Total Common Equity | 1.46 | 3.14 | 4.68 | 1.42 | 0.46 | -0.12 |
Total Liabilities & Equity | 2.16 | 3.58 | 5.95 | 2.01 | 0.96 | 0.12 |
Total Debt | 0.07 | 0.14 | 0.43 | 0.28 | 0.33 | 0.1 |
Net Cash (Debt) | 1.28 | 3.16 | 4.69 | 1.43 | 0.27 | -0.07 |
Net Cash Growth | -43.03% | -32.72% | 227.80% | 420.77% | - | - |
Net Cash Per Share | 1.34 | 4.21 | 9.24 | 3.36 | 1.03 | -0.28 |
Filing Date Shares Outstanding | 1.09 | 0.78 | 0.72 | 0.48 | 0.48 | 0.26 |
Total Common Shares Outstanding | 1.09 | 0.76 | 0.72 | 0.48 | 0.29 | 0.26 |
Working Capital | 1.38 | 3.04 | 4.62 | 1.47 | 0.49 | -0.05 |
Book Value Per Share | 1.34 | 4.16 | 6.51 | 2.94 | 1.61 | -0.46 |
Tangible Book Value | 1.46 | 3.14 | 4.68 | 1.42 | 0.46 | -0.12 |
Tangible Book Value Per Share | 1.34 | 4.16 | 6.51 | 2.94 | 1.61 | -0.46 |
Machinery | 0.14 | 0.14 | 0.13 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.